Glyna
This case was against two individuals.
I think if you look at what % of the amount the two individuals made the percentage is far higher.
The two individuals would be the same as Barnes and Grimaldi in this case who have breached their duties it is claimed.
CHM in their case would be looking for an accounting of their profit which given Grimaldi had a $37 million tax bill gives some idea what was made.
This part and potential win is outside scope of MMX claim
and is an additional source of cash depending on the individuals financial position if CHM win.
Where the case is different is that it is claimed the two indivduals provided a benefit to a company in this case MMX
The plaintiffs in the other case never accused the company itself of misuse of its funds.
In CHM case they claim Nicu had knowledge and therefore willing gained a benefit.
This opens open the direct interest in asset claim which was not available in the case.
- Forums
- ASX - By Stock
- this may be relevant to chm
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

GlynaThis case was against two individuals.I think if you look...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.4¢ | 0.4¢ | 0.4¢ | $19.57K | 4.893M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 419507 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 18587873 | 22 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 419507 | 0.004 |
39 | 26659272 | 0.003 |
15 | 14700506 | 0.002 |
12 | 54600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 17587873 | 20 |
0.006 | 13115184 | 13 |
0.007 | 3100000 | 2 |
0.008 | 8542434 | 6 |
0.009 | 2390797 | 5 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online